Skip to main content
Wolfpack Investor Network

News

Nov 5, 2024

NC State investment arm looks to grow platform, fund more startups

The Wolfpack Investor Network (WIN) and Harbright Ventures are excited to announce a follow-on investment of over $1.75M in SonoVascular, a medical technology company that has developed SonoThrombectomy™, a novel, pharmaco-mechanical, ultrasound-facilitated, and thrombolytic-enhanced thrombectomy system for venous thromboembolism (VTE).

Oct 29, 2024

WIN and Harbright Raise Over $1.75M for SonoVascular

The Wolfpack Investor Network (WIN) and Harbright Ventures are excited to announce a follow-on investment of over $1.75M in SonoVascular, a medical technology company that has developed SonoThrombectomy™, a novel, pharmaco-mechanical, ultrasound-facilitated, and thrombolytic-enhanced thrombectomy system for venous thromboembolism (VTE).

Sep 20, 2024

Wolfpack Investor Network Boosts Investment in Deep Blue Medical 

The Wolfpack Investor Network (WIN) proudly announces a follow-on investment of $290K in Deep Blue Medical Advances, Inc. (Deep Blue), a medical technology company revolutionizing soft tissue surgery with cutting-edge technology that has already improved patient outcomes. 

Jul 19, 2024

Wolfpack Investor Network Celebrates onsemi’s Acquisition of SWIR Vision Systems

The Wolfpack Investor Network (“WIN”) is North Carolina State University’s angel investor group that provides capital and guidance to NC State connected, early-stage companies. WIN has just announced the completion of two investments in Voxel Innovations, Inc. (“Voxel”), a Raleigh based company that machines high-quality metal components using proprietary versions of pulsed electrochemical machining (“PECM”). 

May 21, 2024

Wolfpack Investor Network-Backed Deep Blue Medical Wins Prestigious Luis Villalobos Award

The Wolfpack Investor Network (“WIN”) is North Carolina State University’s angel investor group that provides capital and guidance to NC State connected, early-stage companies. WIN has just announced the completion of a follow-on round of financing for Natrx Inc., a Raleigh based company that uses a proprietary, advanced technology and manufacturing approach to deliver high-performance, nature-based solutions that protect coastal ecosystems and infrastructure.

Nov 22, 2023

This NC food tech company is about more than crops – it’s addressing waste, hunger as well

The Wolfpack Investor Network (“WIN”) is North Carolina State University’s angel investor group that provides capital and guidance to NC State connected, early-stage companies. WIN has just announced the completion of a follow-on round of financing for Natrx Inc., a Raleigh based company that uses a proprietary, advanced technology and manufacturing approach to deliver high-performance, nature-based solutions that protect coastal ecosystems and infrastructure.

Nov 14, 2023

Wolfpack Investor Network Boosts Natrx Inc. for Eco-Friendly Coastal Solutions

The Wolfpack Investor Network (“WIN”) is North Carolina State University’s angel investor group that provides capital and guidance to NC State connected, early-stage companies. WIN has just announced the completion of a follow-on round of financing for Natrx Inc., a Raleigh based company that uses a proprietary, advanced technology and manufacturing approach to deliver high-performance, nature-based solutions that protect coastal ecosystems and infrastructure.

Oct 27, 2023

Wolfpack Investor Network Supports Raleigh-Based Voxel with Fresh Capital

The Wolfpack Investor Network (“WIN”) is North Carolina State University’s angel investor group that provides capital and guidance to NC State connected, early-stage companies. WIN has just announced the completion of two investments in Voxel Innovations, Inc. (“Voxel”), a Raleigh based company that machines high-quality metal components using proprietary versions of pulsed electrochemical machining (“PECM”). 

Oct 26, 2023

WIN Backs SonoVascular Ahead of Clinical Trials

Research Triangle Park medical company SonoVascular is one step closer to improving treatment for those with venous thromboembolism after securing capital and resources from the Wolfpack Investor Network. The Wolfpack Investor…

Dec 5, 2022

Deep Blue Medical Advances Announces FDA Clearance for Sublay Application in Hernia Surgery, Enabling Broader Use of T-Line Hernia Mesh

Deep Blue Medical Advances announced today it has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its T-Line® Hernia Mesh for the sublay technique in open hernia surgery.